Archives
-
Arachidonic Acid for Reliable Cell Assays
2026-09-13
A practical, scenario-based guide to using Arachidonic Acid (SKU C4223) in cell viability, proliferation, and cytotoxicity workflows. It addresses solvent compatibility, concentration design, pathway interpretation, vendor selection, and evidence limitations for reproducible lipid-signaling experiments.
-
Rucaparib, Splicing, and PARP Sensitivity
2026-09-12
Rucaparib (AG-014699, PF-01367338) offers a practical framework for studying how DNA repair state, radiation response, transporter biology, and spliceosome regulation shape PARP inhibitor sensitivity. Integrating product intelligence with a 2024 Nature Communications study on SmD2 acetylation, this article outlines translational experiments that connect HCC spliceosome biology with prostate cancer radiosensitization while distinguishing evidence from forward-looking hypotheses.
-
Isochlorogenic Acid A: From Molecule to Wound Repair
2026-09-11
Isochlorogenic acid A is moving from natural-product discovery toward formulation-led wound-repair research. This article examines its chemistry, Fe(III)-coassembled hydrogel evidence, experimental controls, translational limits, and strategic next steps for reproducible anti-infection, immunology, and inflammation research.
-
DiscoveryProbe Immunology/Inflammation Compound Library
2026-09-11
Convert a curated 295-compound collection into actionable immune pathway profiling, target validation, and phenotypic inflammation screening data. This workflow combines pre-dissolved small molecules with multiplex PBMC flow cytometry to separate pathway modulation, immune-cell activation, and nonspecific toxicity.
-
EZH2 Inhibition in HPV-Associated Cervical Cancer
2026-09-10
The reference study evaluates EPZ6438 and ZLD1039 as EZH2 inhibitors in HPV-positive and HPV-negative cervical cancer models, combining proliferation, apoptosis, cell-cycle, molecular, and chorioallantoic membrane readouts. Its main contribution is linking EZH2 inhibition with reduced HPV16 E6/E7 expression, increased p53 and Rb signals, epithelial-marker recovery, and stronger activity of EPZ6438 in HPV-positive cells, while also defining the limits of this preliminary evidence.
-
IAM LC vs LEKC for Pulmonary Drug Permeability
2026-09-10
This 2024 Journal of Chromatography A study provides a direct comparison of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography for modelling drug–membrane partitioning and pulmonary permeability. LEKC more closely reflected apparent lung permeability for the tested compounds, whereas IAM LC offered broader compound coverage and simpler, more automation-friendly analysis.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-09-09
HyperFluor 488 Goat Anti-Rabbit IgG provides fluorescent detection of rabbit primary antibodies in immunofluorescence, immunocytochemistry, fluorescence microscopy, and flow cytometry. It should not be used to detect non-rabbit primary antibodies or treated as a directly labeled primary antibody, and its sodium azide-containing buffer requires compatibility review for live-cell workflows.
-
Cisapride as a Dual-Readout Cardiac Stressor
2026-09-09
Cisapride (R 51619) offers a mechanistically informative challenge for cardiac electrophysiology research. This article presents a dual-readout framework that connects 5-HT4 receptor signaling, hERG channel inhibition, high-content imaging, and deep-learning phenotyping.
-
Polyploid Giant Cancer Macrophages in Blood
2026-09-08
The reference study characterizes circulating cancer-associated macrophage-like cells (CAMLs) as phagocytic polyploid giant cells with mixed myeloid, epithelial, and endothelial features. In a prospective multi-institutional cohort, CAMLs correlated with disease progression and spread, supporting their investigation as blood-based indicators of metastatic biology while leaving their cellular origin and causal role unresolved.
-
DMXAA (Vadimezan) Workflows for Tumor Vascular Studies
2026-09-08
DMXAA (Vadimezan) links tumor-vessel disruption, VEGFR2 signaling, and apoptosis readouts in practical cancer biology assays. This guide combines reproducible dosing and formulation advice with a nanorod-based STING application that extends DMXAA research toward immune-enabled tumor models.
-
Carvedilol Phosphate in Hepatic IRI Research
2026-09-07
Carvedilol Phosphate offers a practical way to interrogate broad adrenergic signaling in hepatic ischemia–reperfusion injury models, from hepatocyte stress assays to macrophage co-cultures. This workflow-focused guide covers formulation, experimental controls, assay selection, and troubleshooting while separating reference-backed findings from proposed optimization steps.
-
Crystal Violet: From Biofilm Readout to Translation
2026-09-07
A mechanistic and strategic guide to using Crystal Violet Staining Solution for interpretable biofilm, nuclear staining, migration, invasion, proliferation, and colony formation workflows.
-
Neuromedin S (rat): Protocol and QC Guide
2026-09-05
Neuromedin S (rat), SKU B5466, provides a defined peptide agonist for controlled studies of neuromedin U receptor signaling and related GPCR/G protein signaling workflows. It is intended for laboratory research only, not diagnostic or therapeutic use, and the supplied information does not establish assay-specific potency, dosing, or clinical relevance.
-
Merbromin Workflows for Binding and Protease Assays
2026-09-04
Merbromin combines fluorescence-based protein binding analysis with enzyme inhibition and antimicrobial screening utility. This practical guide connects assay setup, matrix-aware optimization, environmental handling, and troubleshooting for more reliable biochemical data.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-09-04
A 2025 European Journal of Cell Biology study established a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids could be propagated, cryopreserved, and converted into epithelial monolayers containing metabolically and transporter-active enterocytes, providing a more human-relevant platform for pharmacokinetic research.